Paper40933709
Pharmacometric modeling of lipid nanoparticle-encapsulated mRNA therapeutics and vaccines: A systematic review.
Zhang M and 2 others. Mol Ther Nucleic Acids, 2025. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Pharmacometric modeling of lipid nanoparticle-encapsulated mRNA therapeutics and vaccines: A systematic review. Papers, record 40933709. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40933709
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pharmacometric modeling of lipid nanoparticle-encapsulated mRNA therapeutics and vaccines: A systematic review.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References132
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29683383 | Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility. | Nucleic Acid Ther | 2018 | https://conductscience.org/library/papers/29683383 | PubMed |
| 2 | 24412220 | Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner. | Neurobiol Dis | 2014 | https://conductscience.org/library/papers/24412220 | PubMed |
| 3 | 39644458 | All You Need to Know About Allometric Scaling: An Integrative Review on the Theoretical Basis, Empirical Evidence, and Application in Human Pharmacology. | Clin Pharmacokinet | 2025 | https://conductscience.org/library/papers/39644458 | PubMed |
| 4 | 34887572 | A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus. | Nat Med | 2021 | https://conductscience.org/library/papers/34887572 | PubMed |
| 5 | 23071855 | The Ubiquitin Proteasome Pathway (UPP) in the regulation of cell cycle control and DNA damage repair and its implication in tumorigenesis. | Int J Clin Exp Pathol | 2012 | https://conductscience.org/library/papers/23071855 | PubMed |
| 6 | 27423426 | Liver sinusoidal endothelial cells: Physiology and role in liver diseases. | J Hepatol | 2017 | https://conductscience.org/library/papers/27423426 | PubMed |
| 7 | 31768005 | Lysosomes as dynamic regulators of cell and organismal homeostasis. | Nat Rev Mol Cell Biol | 2020 | https://conductscience.org/library/papers/31768005 | PubMed |
| 8 | 32133631 | Disease pharmacokinetic-pharmacodynamic modelling in acute intermittent porphyria to support the development of mRNA-based therapies. | Br J Pharmacol | 2020 | https://conductscience.org/library/papers/32133631 | PubMed |
| 9 | 23423192 | Protein corona significantly reduces active targeting yield. | Chem Commun (Camb) | 2013 | https://conductscience.org/library/papers/23423192 | PubMed |
| 10 | 20461061 | Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. | Mol Ther | 2010 | https://conductscience.org/library/papers/20461061 | PubMed |
| 11 | 9651253 | Visualization of specific B and T lymphocyte interactions in the lymph node. | Science | 1998 | https://conductscience.org/library/papers/9651253 | PubMed |
| 12 | 32786370 | The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy. | Bioconjug Chem | 2020 | https://conductscience.org/library/papers/32786370 | PubMed |
| 13 | 37499908 | An artificial intelligence-assisted physiologically-based pharmacokinetic model to predict nanoparticle delivery to tumors in mice. | J Control Release | 2023 | https://conductscience.org/library/papers/37499908 | PubMed |
| 14 | 35953550 | Identifying cell receptors for the nanoparticle protein corona using genome screens. | Nat Chem Biol | 2022 | https://conductscience.org/library/papers/35953550 | PubMed |
| 15 | 39373269 | Impact of Lipid Tail Length on the Organ Selectivity of mRNA-Lipid Nanoparticles. | Nano Lett | 2024 | https://conductscience.org/library/papers/39373269 | PubMed |
| 16 | 36154076 | Lipid Nanoparticle (LNP) Chemistry Can Endow Unique In Vivo RNA Delivery Fates within the Liver That Alter Therapeutic Outcomes in a Cancer Model. | Mol Pharm | 2022 | https://conductscience.org/library/papers/36154076 | PubMed |
| 17 | 24056901 | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. | Nat Nanotechnol | 2013 | https://conductscience.org/library/papers/24056901 | PubMed |
| 18 | 34451973 | Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/34451973 | PubMed |
| 19 | 31449666 | A Minimal Physiologically-Based Pharmacokinetic Model Demonstrates Role of the Neonatal Fc Receptor (FcRn) Competition in Drug-Disease Interactions With Antibody Therapy. | Clin Pharmacol Ther | 2020 | https://conductscience.org/library/papers/31449666 | PubMed |
| 20 | 33510170 | Surface chemistry-mediated modulation of adsorbed albumin folding state specifies nanocarrier clearance by distinct macrophage subsets. | Nat Commun | 2021 | https://conductscience.org/library/papers/33510170 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42851665 | Mechanisms and determinants of mRNALipid Nanoparticle biodistribution: From pharmacokinetics to clinical translation. | Bioeng Transl Med | 2026 | https://conductscience.org/library/papers/42851665 | PubMed |
| 42677161 | Overcoming hepatic tropism: Precision engineering of lipid nanoparticles for extrahepatic RNA delivery. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42677161 | PubMed |
| 42568897 | Physiologically based pharmacokinetic modeling of mRNA therapeutics: A multiscale framework for LNP and antibody trafficking in mice. | Mol Ther Nucleic Acids | 2026 | https://conductscience.org/library/papers/42568897 | PubMed |
| 42193283 | Functionalized Lipid Nanoparticles for Targeted RNA Delivery in Immune and Inflammatory Diseases. | Biomedicines | 2026 | https://conductscience.org/library/papers/42193283 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40933709
GET https://conductscience.org/api/papers/v1/40933709/references?page=2